Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
…, S Rahman, A Rastogi, SM Riordan, P Sakhuja… - Hepatology …, 2009 - Springer
The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on
acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus …
acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus …
[HTML][HTML] Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
P Sakhuja - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
The liver involvement in alcoholic liver disease (ALD) classically ranges from alcoholic
steatosis, alcoholic hepatitis or steatohepatitis, alcoholic cirrhosis and even hepatocellular …
steatosis, alcoholic hepatitis or steatohepatitis, alcoholic cirrhosis and even hepatocellular …
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)
…, G Esmat, W Doss, T Elzanaty, P Sakhuja… - Hepatology …, 2009 - Springer
Liver fibrosis is a common pathway leading to cirrhosis, which is the final result of injury to the
liver. Accurate assessment of the degree of fibrosis is important clinically, especially when …
liver. Accurate assessment of the degree of fibrosis is important clinically, especially when …
[HTML][HTML] Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
…, M Wadhawan, S Gupta, K Madan, P Sakhuja… - Hepatology …, 2019 - Springer
The first consensus report of the working party of the Asian Pacific Association for the Study
of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in …
of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in …
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
Background & Aims: There is a paucity of data on hepatitis B virus (HBV) DNA levels and
histologic lesions in patients with chronic HBV (CHBV) infection and persistently normal …
histologic lesions in patients with chronic HBV (CHBV) infection and persistently normal …
Granulocyte colony–stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure
…, N Trehanpati, A Kumar, BC Sharma, P Sakhuja… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) develops in patients with
chronic liver disease and has high mortality. Mobilization of bone marrow–derived stem cells …
chronic liver disease and has high mortality. Mobilization of bone marrow–derived stem cells …
[HTML][HTML] Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 …
…, S Hamid, Z Abbas, P Bedossa, P Sakhuja… - Hepatology …, 2017 - Springer
Hepatic fibrosis is a common pathway leading to liver cirrhosis, which is the end result of
any injury to the liver. Accurate assessment of the degree of fibrosis is important clinically, …
any injury to the liver. Accurate assessment of the degree of fibrosis is important clinically, …
Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
…, S Garg, R Chauhan, P Sakhuja… - Official journal of the …, 2004 - journals.lww.com
BACKGROUND: Tumor necrosis factor-α (TNF-α) has been incriminated to play an important
role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Pentoxifylline, a TNF-α …
role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Pentoxifylline, a TNF-α …
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment
…, H Qureshi, RM Raza, P Sahni, P Sakhuja… - Hepatology …, 2007 - Springer
The Asian Pacific Association for the Study of the Liver (APASL) Working Party on Portal
Hypertension has developed consensus guidelines on the disease profile, diagnosis, and …
Hypertension has developed consensus guidelines on the disease profile, diagnosis, and …
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non‐alcoholic steatohepatitis
SK Satapathy, P Sakhuja, V Malhotra… - Journal of …, 2007 - Wiley Online Library
Background and Aim: Inhibition of tumor necrosis factor (TNF)‐α is a logical approach to
manage patients with non‐alcoholic steatohepatitis (NASH). Pentoxifylline reduces TNF‐α and …
manage patients with non‐alcoholic steatohepatitis (NASH). Pentoxifylline reduces TNF‐α and …
